Mannkind (MNKD) EBT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 596.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 596.00 |
| Dec 31, 2025 | 3,108.00 |
| Sep 30, 2025 | 5,344.00 |
| Jun 30, 2025 | 967,556.00 |
| Mar 31, 2025 | 23,417.00 |
| Dec 31, 2024 | 23,522.00 |
| Sep 30, 2024 | 3,829.00 |
| Jun 30, 2024 | 15,025.00 |
| Mar 31, 2024 | 9,052.00 |
| Dec 31, 2023 | 14,827.00 |
| Sep 30, 2023 | 7,809.00 |
| Jun 30, 2023 | 511,517.00 |
| Mar 31, 2023 | 3,331.00 |
| Dec 31, 2022 | 3,404.00 |
| Sep 30, 2022 | 143,746.00 |
| Jun 30, 2022 | -348,083.00 |
| Mar 31, 2022 | -13,150.00 |
| Dec 31, 2021 | -17,916.00 |
| Sep 30, 2021 | 52,087.00 |
| Jun 30, 2021 | 42,370.00 |
| Mar 31, 2021 | 80,284.00 |
| Dec 31, 2020 | -193,009.00 |
| Sep 30, 2020 | 153,496.00 |
| Jun 30, 2020 | -349,220.00 |
| Mar 31, 2020 | 48,509.00 |
| Dec 31, 2019 | -51,895.00 |
| Sep 30, 2019 | -155,936.00 |